Hepatitis Awareness Month is held every May to raise awareness about viral hepatitis, an inflammation of the liver caused…
Articles by Margarida Maia, PhD
Exposure to high levels of fine particulate matter, or PM2.5, the most commonly studied air pollutant, and reduced time in…
A study of three children with progressive familial intrahepatic cholestasis type 3 (PFIC3) in China revealed that different disease-causing…
Measuring the blood levels of bile acids, the main component of the digestive fluid bile, can help predict key clinical…
Among second-line treatments for primary biliary cholangitis (PBC), Iqirvo (elafibranor) may work better than Livdelzi (seladelpar) at reducing markers…
A young woman in the U.S. who experienced recurrent cholestasis was later found, with the help of genetic testing,…
Domenic Frappolli, who was born with biliary atresia, was named the American Liver Foundation’s (ALF) 2025 National LIVEr Champion.
Gilead Sciences’ oral therapy seladelpar has been conditionally approved by the European Commission as a second-line therapy for…
A specific variant in the ABCB4 gene does not cause intrahepatic cholestasis of pregnancy (ICP) on its own, but…
New artificial intelligence (AI) models based on 11 possible risk factors of intrahepatic cholestasis of pregnancy (ICP) can accurately…